Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds

被引：0
|
作者：
Atatreh, Noor [1 ,2 ]
Mahgoub, Radwa E. [1 ,2 ]
Ghattas, Mohammad A. [1 ,2 ]
机构：
[1] Al Ain Univ, Coll Pharm, Abu Dhabi, U Arab Emirates
[2] Al Ain Univ, AAU Hlth & Biomed Res Ctr, Abu Dhabi, U Arab Emirates
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2025年 / 40卷 / 01期
关键词：
Anti-viral; irreversible inhibition; covalent inhibitor; Covid-19; warheads reactivity; PEPTIDE ALDEHYDE INHIBITORS; COV M-PRO; 3C-LIKE PROTEASE; CRYSTAL-STRUCTURES; DESIGN; DISCOVERY; PROTEINASE; REVEALS; TARGET; SITE;
D O I：
10.1080/14756366.2025.2460045
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Peptidomimetic inhibitors mimic natural peptide substrates, employing electrophilic warheads to covalently interact with the catalytic Cys145 of Mpro. Examples include aldehydes, alpha-ketoamides, and aza-peptides, with discussions on their mechanisms of action, potency, and structural insights. Non-peptidomimetic inhibitors utilise diverse scaffolds and mechanisms, achieving covalent modification of Mpro.
引用
收藏
页数：26
相关论文
共 50 条
  • [41] Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
    Liu, Sen
    Zheng, Qiang
    Wang, Zhiying
    BIOINFORMATICS, 2020, 36 (11) : 3295 - 3298
  • [42] Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
    Abel, Renata
    Ramos, Maria Paredes
    Chen, Qiaofeng
    Perez-Sanchez, Horacio
    Coluzzi, Flaminia
    Rocco, Monica
    Marchetti, Paolo
    Mura, Cameron
    Simmaco, Maurizio
    Bourne, Philip E.
    Preissner, Robert
    Banerjee, Priyanka
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [43] Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
    Son Tung Ngo
    Ngoc Quynh Anh Pham
    Ly Thi Le
    Duc-Hung Pham
    Vu, Van V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5771 - 5780
  • [44] A Genetic Trap in Yeast for Inhibitors of SARS-CoV-2 Main Protease
    Alalam, Hanna
    Sigurdardottir, Sunniva
    Bourgard, Catarina
    Tiukova, Ievgeniia
    King, Ross D.
    Grotli, Morten
    Sunnerhagen, Per
    MSYSTEMS, 2021, 6 (06)
  • [45] Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease
    DeLaney, Christopher
    Sheng, Yan
    Pectol, D. Chase
    Vantansever, Erol
    Zhang, Hanyuan
    Bhuvanesh, Nattamai
    Salas, Isaiah
    Liu, Wenshe R.
    Fierke, Carol F.
    Darensbourg, Marcetta Y.
    DALTON TRANSACTIONS, 2021, 50 (35) : 12226 - 12233
  • [46] De novo Design of SARS-CoV-2 Main Protease Inhibitors
    Fischer, Christian
    Veprek, Nynke A.
    Peitsinis, Zisis
    Ruhmann, Klaus-Peter
    Yang, Chao
    Spradlin, Jessica N.
    Dovala, Dustin
    Nomura, Daniel K.
    Zhang, Yingkai
    Trauner, Dirk
    SYNLETT, 2022, 33 (05) : 458 - 463
  • [47] The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
    Pang, Xiaojing
    Liu, Yang
    Li, Hua
    Chen, Lixia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
  • [48] Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach
    Lima, Adrianne M.
    de Souza, Adson A.
    Amaral, Jackson L.
    Freire, Valder N.
    Souza, Pedro F.
    de Oliveira, Hermogenes D.
    FUTURE VIROLOGY, 2023, 18 (07) : 439 - 454
  • [49] Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Simulation Analysis Study
    Xiong, Fei
    Zhang, Yan-Jun
    Jiang, Hui-Ying
    Wang, Zhong-Hua
    CHEMISTRY & BIODIVERSITY, 2024, 21 (05)
  • [50] Identification of prospective covalent inhibitors for SARS-CoV-2 main protease using structure-based approach
    Gayatri, Shenvi Kudchadker
    Chhabra, Vaishnavi
    Kumar, Harish
    Sobhia, M. Elizabeth
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (16): : 7913 - 7930
12345